摘要
目的:研究莫西沙星治疗老年性肺炎的临床疗效和安全性。方法:将130例老年性肺炎患者随机分为治疗组和对照组各65例,治疗组采用莫西沙星治疗,对照组接受头孢曲治疗,疗程均为7天。观察两组患者的临床疗效和不良反应。结果:治疗组总有效率为92.31%,对照组总有效率为80.00%,两组临床疗效差异有显著性(P<0.05);治疗组与对照组的不良反应发生率差异无显著性(P>0.05)。结论:莫西沙星治疗老年性肺炎,可明显的提高临床疗效,缩短疾病病程,具有良好的临床效果。
Objective：To study the eficacy and safety of moxifloxacing treatment effect on senile pneumonia. Methods ：130 patients with senile pneumonia were randomly divided into two groups ：65 in treatment group（ the patients were treated with moxifloxacin） ;65 in control group（ the patients were treated with ceftriaxone）. Both groups were treated for 7days. Eficaey and safety of both group were evaluated. Results：The overall eficacy was 92.31% for the treatment group and 80.00% for the control group. Between the two groups there were significant ditterenees （ P 〈 0.05 ）. Conclusion ： Moxifloxacin in thetreatment of senile pneumonia could obviously improve ehnical efficacy, shorten the diseasc＇s develop course, and have a good clinical prospect.
出处
《医学信息（中旬刊）》
2010年第12期3739-3740,共2页
Medical Information Operations Sciences Fascicule
